Product Information
DOXEPIN 150 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $0.5095 per EA under NDC 69315016301. Its NADAC has been published 125 times since Sep 7, 2022.
FDA first approved this application on Mar 1, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315016301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211618FDA Approved
3/1/2021
TE Code
AB
On Market Since
4/15/2021
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 150 MG CAPSULE has been published 125 times since Sep 7, 2022, and over the history we have for it it has declined 22.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5095 per EA |
|---|---|
| All-time high | $0.7133 (May 10, 2023) |
| All-time low | $0.4876 (Mar 20, 2024) |
| 52-week high | $0.5631 |
| 52-week low | $0.4964 |
| Median price | $0.6245 |
| Average price | $0.6037 |
| Largest weekly change | -27.4% (Mar 20, 2024) |
| Weeks tracked | 125 |
| Tracking since | Sep 7, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
+0.0%
1Y
-12.6%
3Y
-25.2%
5Y
N/A
All
-22.7%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 150 MG CAPSULE, manufactured by Leading Pharma, LLC, is $0.5095 per EA (NDC 69315016301), effective Apr 29, 2026.
How has the price of DOXEPIN 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 150 MG CAPSULE has declined 22.7%. It has been tracked across 125 weekly CMS publications since Sep 7, 2022.
What are the highest and lowest recorded NADAC prices for DOXEPIN 150 MG CAPSULE?
Since Sep 7, 2022, the NADAC for DOXEPIN 150 MG CAPSULE has ranged from a low of $0.4876 (Mar 20, 2024) to a high of $0.7133 (May 10, 2023), with a median of $0.6245 per EA.
Are there cheaper alternatives to DOXEPIN 150 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXEPIN 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXEPIN 150 MG CAPSULE?
DOXEPIN 150 MG CAPSULE (NDC 69315016301) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.